-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 ThvIjfnbRMIpoKq4m//8+UJQ/CFSQ0kDN8mLB6wn9gMaDFf215a9fypTDF++Lddg
 FnHRut4tTphtYCZ6wQGS2w==

<SEC-DOCUMENT>0001295345-09-000032.txt : 20090514
<SEC-HEADER>0001295345-09-000032.hdr.sgml : 20090514
<ACCEPTANCE-DATETIME>20090514141653
ACCESSION NUMBER:		0001295345-09-000032
CONFORMED SUBMISSION TYPE:	NT 10-Q
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090331
FILED AS OF DATE:		20090514
DATE AS OF CHANGE:		20090514
EFFECTIVENESS DATE:		20090514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZAXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		NT 10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15746
		FILM NUMBER:		09825831

	BUSINESS ADDRESS:	
		STREET 1:		6399 WILSHIRE BOULEVARD
		STREET 2:		SUITE 1019
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90048
		BUSINESS PHONE:		(323) 951-0575

	MAIL ADDRESS:	
		STREET 1:		6399 WILSHIRE BOULEVARD
		STREET 2:		SUITE 1019
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90048

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFERGENE CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>zxsi_nt.htm
<TEXT>
<!-- saved from url=(0022)http://internet.e-mail -->
<html>

<head>
<title>zxsi</title>
</head>

<body>
<b><font SIZE="5">

<p ALIGN="CENTER"></font><font size="4">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION</font></b></p>

<p ALIGN="CENTER"><font size="4">Washington, D.C. 20549</font></p>

<p ALIGN="CENTER">&nbsp;</p>

<p ALIGN="CENTER"><font SIZE="5"><strong>ZAXIS INTERNATIONAL INC.<br>
</strong></font><font size="1">(Full Name of Registrant)</font></p>

<p ALIGN="CENTER"><font size="4">FORM 12b-25</font></p>

<p ALIGN="CENTER">NOTIFICATION OF LATE FILING</p>

<p ALIGN="CENTER"><font SIZE="2">SEC FILE NUMBER: [0-15476]</font></p>

<p><font SIZE="2">(Check One): [<strong>&nbsp; </strong>]Form 10-K [ ] Form 20-F [ ]Form
11-K [<b> </b>] Form 10Q [X] Form N-SAR [ ]</font></p>

<p><font SIZE="2">For Period Ended: <br>
[ ] Transition Report on Form 10-K<br>
[ ] Transition Report on Form 20-F<br>
[ ] Transition Report on Form 11-K<br>
[ ] Transition Report on Form 10-QSB<br>
[ ] Transition Report on Form N-SAR<br>
For the Transition Period Ended: </font></p>

<p><font SIZE="2">Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein. If the notification relates to a portion of the
filing checked above, identify the Item(s) to which the notification relates:</font></p>

<p align="center"><b><font SIZE="2">PART I - REGISTRATION INFORMATION</font></b></p>

<table border="0" cellspacing="0" width="100%">
  <tr>
    <td width="100%" align="center"><font size="3">Zaxis International Inc.</font></td>
  </tr>
  <tr>
    <td width="100%" align="center"><font SIZE="2">6399 Wilshire Blvd., Suite 10019, Los
    Angeles, CA 90048</font></td>
  </tr>
  <tr>
    <td width="100%" align="center"><font size="1">Address of&nbsp; Principal Executive Office
    (Street and Number)</font></td>
  </tr>
</table>
<b>

<p align="center"><font SIZE="2">PART II - RULE 12b-25(b)</font></p>
</b>

<p ALIGN="JUSTIFY"><font SIZE="2">If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)</font></p>

<p ALIGN="JUSTIFY"><font SIZE="2">[X] (a) The reasons described in reasonable detail in
Part III of this form could not be eliminated without unreasonable effort or expense;</font></p>

<p ALIGN="JUSTIFY"><font SIZE="2">[X] (b) The subject annual report on Form 10-K will be
filed on or before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof will be
filed on or before the fifth calendar day following the prescribed due date.</font></p>
<b>

<p align="center"><font SIZE="2">PART III - NARRATIVE</font></p>
</b>

<p ALIGN="JUSTIFY"><font SIZE="2">The Registrant's annual report on Form 10-K could not be
filed within the prescribed time period because the Registrant encountered delays in its
preparation of its audited financial statements.</font></p>
<b>

<p align="center"><font SIZE="2">PART IV - OTHER INFORMATION</font></p>
</b>

<p><font SIZE="2">(1) Name and telephone number of person to contact in regard to this
notification.</font></p>

<table border="0" cellspacing="0" width="100%">
  <tr>
    <td width="100%" align="center"><font SIZE="2">Ivo Heiden, CEO</font></td>
  </tr>
  <tr>
    <td width="100%" align="center"><font size="1">(Name)</font></td>
  </tr>
  <tr>
    <td width="100%" align="center"><font SIZE="2">(323) 951-0575</font></td>
  </tr>
  <tr>
    <td width="100%" align="center"><font size="1">(Area Code) (Telephone Number)</font></td>
  </tr>
</table>

<p ALIGN="JUSTIFY"><font SIZE="2">(2) Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no, identify
report(s).</font></p>

<p ALIGN="CENTER"><font SIZE="2">[<b>X</b>] Yes [ ] No</font></p>

<p ALIGN="JUSTIFY"><font SIZE="2">(3) Is it anticipated that any significant changes in
results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion
thereof?</font></p>

<p ALIGN="CENTER"><font SIZE="2">[&nbsp; ] Yes [<b>X</b>] No</font></p>

<p ALIGN="JUSTIFY"><font SIZE="2">If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.</font></p>

<p ALIGN="center"><font SIZE="2">____________________________________________________</font></p>

<p align="center"><font size="3"><u>Zaxis International Inc.<br>
</u></font><font size="1">Name of Registrant as Specified in Charter</font></p>

<p><font SIZE="2">has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.</font></p>

<table border="0" cellpadding="0" width="100%" cellspacing="0">
  <tr>
    <td width="100%"><font SIZE="2">By: Ivo Heiden, CEO and Chairman</font></td>
  </tr>
  <tr>
    <td width="100%"><font SIZE="2">Date: May 13, 2009</font></td>
  </tr>
  <tr>
    <td width="100%"><font SIZE="2">By /s/ Ivo Heiden</font></td>
  </tr>
</table>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
